 CHERRY HILL, N.J., May 10, 2022 GLOBE NEWSWIRE -- Vyant Bio, Inc. Vyant Bio, Company Nasdaq: VYNT is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Companys central nervous system CNS drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. Today, Vyant Bio announced that an investor conference call and webcast will be hosted on Monday, May 16, 2022. 